These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6098392)

  • 1. Diuretic and haemodynamic effects of MK 447 in normotensive and hypertensive sheep.
    Humphery TJ; Coghlan JP; Denton DA; Fei DW; Graham WF; Scoggins BA; Whitworth JA
    Clin Exp Pharmacol Physiol; 1984; 11(5):483-7. PubMed ID: 6098392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats.
    Schiffrin EL; Gutkowska J; Thibault G; Genest J
    Can J Physiol Pharmacol; 1984 Jan; 62(1):116-23. PubMed ID: 6143602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.
    Brunner DB; Desponds G; Biollaz J; Keller I; Ferber F; Gavras H; Brunner HR; Schelling JL
    Br J Clin Pharmacol; 1981 May; 11(5):461-7. PubMed ID: 6268131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep.
    Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unrelated responses of brachial artery hemodynamics and renin-angiotensin system to acute converting enzyme inhibition by enalaprilat in essential hypertension.
    Levenson J; Chau NP; Billaud E; Simon A
    Am J Cardiol; 1988 May; 61(13):1056-60. PubMed ID: 2834938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of the new angiotensin-converting-enzyme inhibitor, cilazapril, in anesthetized and conscious dogs.
    Holck M; Fischli W; Hefti F; Gerold M
    J Cardiovasc Pharmacol; 1986; 8(1):99-108. PubMed ID: 2419701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
    Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
    Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure and patients with hypertension.
    Schwartz JB; Taylor A; Abernethy D; O'Meara M; Farmer J; Young J; Nelson E; Pool J; Mitchell JR
    J Cardiovasc Pharmacol; 1985; 7(4):767-76. PubMed ID: 2410720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACTH hypertension modifies the haemodynamic effects of prostacyclin infusions in sheep.
    Mason RT; Allen KJ; Coghlan JP; Denton DA; Fei DT; Graham WF; Scoggins BA; Stewart KW
    Clin Exp Pharmacol Physiol; 1980; 7(5):469-72. PubMed ID: 6256103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibition does not prevent development of ACTH-induced hypertension in sheep.
    Spence CD; Coghlan JP; Denton DA; Fei DT; Mills EH; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1985; 12(2):181-5. PubMed ID: 2988839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure.
    Sweet CS; Ludden CT; Frederick CM; Ribeiro LG
    Am J Med; 1984 Aug; 77(2A):7-12. PubMed ID: 6089558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin synthesis inhibition with indomethacin in ACTH-induced hypertension.
    Mason RT; Coghlan JP; Denton DA; Graham WF; Humphery TJ; Scoggins BA; Whitworth JA
    J Cardiovasc Pharmacol; 1984; 6(2):288-92. PubMed ID: 6200718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic, hormonal, and diuretic effects of felodipine in healthy normotensive volunteers.
    Sluiter HE; Huysmans FT; Thien TA; van Lier HJ; Koene RA
    Drugs; 1985; 29 Suppl 2():26-35. PubMed ID: 2985351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
    J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M; Schiavi P; Vincent M; Schmitt H
    J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure.
    Sweet CS; Ludden CT; Frederick CM; Bush LR; Ribeiro LG
    J Cardiovasc Pharmacol; 1984; 6(6):1067-75. PubMed ID: 6084762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of iloprost on blood pressure, heart rate, renal hemodynamics, diuresis, natriuresis, plasma renin activity and plasma norepinephrine in uninephrectomized hypertensive mongrel dogs.
    Villa E; Morales ME; Martinez J; de la Fuente A; Hurtado A; Santirso RA; Ruilope LM; Sancho JM; GarcĂ­a-Robles R
    J Hypertens Suppl; 1991 Dec; 9(6):S352-3. PubMed ID: 1726369
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of renal but not haemodynamic effects of atrial natriuretic peptide (1-28) in sheep treated with ACTH.
    Parkes DG; Coghlan JP; McDougall JG; Scoggins BA
    Clin Exp Pharmacol Physiol; 1988 Dec; 15(12):945-53. PubMed ID: 2854018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
    Fouad FM; Tarazi RC; Bravo EL; Textor SC
    Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilat.
    Neutel JM; Luther RR; Boger RS; Weber MA
    Am Heart J; 1991 Oct; 122(4 Pt 1):1094-100. PubMed ID: 1656720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.